Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ranibizumab vs Dexamethasone in CRVO (COMRADE-C)
NCT01396083Phase 3Completed
- Sponsor
- Novartis
- Start
- Aug 2011
- Primary completion
- Jan 2014
- Modality
- Antibody Fragments, Antibody Conjugates, Monoclonal Antibodies
- Countries
- 4
01
Overview
A Phase 3 trial of ranibizumab in macular edema, sponsored by Novartis. Started Aug 2011; status: completed.
02
Drugs
ranibizumab
03
Conditions
macular edema
Beyond the preview
Go deeper on NCT01396083.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01396083.